Company attributes
Industry
Location
B2X
AngelList URL
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Email Address
entrepreneur@aurigapartners.com
Full Address
14, Bd de la Madeleine, 75008 Paris, France0
Founded Date
1998
Glassdoor ID
Key People
Wellfound ID
Country
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Auriga Partners is a Paris, France based venture capital investment firm that prefers to invest in companies operating in the information technology, communication technology and life sciences sectors. The firm was founded in 1998.
Investment
Auriga Partners has made investments in Exeliom, Flash Therapeutics, EnobraQ, Pherecydes Pharma, aveni, Vectalys, VitaDX, Nosopharm, TxCell, One More Company, Nexthink, Pylote and CoLucid Pharmaceuticals.
They exited their investments in Innate Pharma, Ekinops, Genocea Biosciences, Median Technologies, Gamida Cell, Neolane, TiGenix, CellNovo, SuperSonic Imagine, Eptica and Wallix.
Funds
Auriga Partners raised their Auriga IV Bioseeds fund for a total of €42.3 million. This fund was announced on Nov 19, 2013.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
